Zero tolerance for counterfeit medicines
Date
27 May 2008
Sections
Health & Consumers
Counterfeit medicines, already widespread in the developing world, are now being found increasingly in the EU. While Internet-based sales are the main source of counterfeit medicines, these products are also appearing in the traditional supply chain. Urgent measures are required to protect European patients,
including a ban on medicine repackaging.
Agenda
18 Nov 2024
21 Oct 2024
15 Oct 2024
25 Jun 2024
17 Jun 2024
Jobs
LEYTON Benelux
CSR Europe
SEC Newgate EU
European Patients' Forum
ETUC/CES
International Federation for Spina Bifida and Hydrocephalus
Brussels Signal